ISSN: 0975-0851
Statistical considerations in biosimilar assessment using biosimilarity index
In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation
View More »
Journal of Bioequivalence & Bioavailability received 4890 citations as per Google Scholar report
Research Article
Comparative Bioavailability Study of Rybelsus (Semaglutide) 3 mg Tablets of Novo Nordisk Versus Ozempic (Semaglutide) 2 mg/1.5 ml (1.34 mg/ml) Solution for Injection of Novo Nordisk under Fasting Condition in Healthy Subjects
DOI: 10.35248/0975-0851.24.16.606
Novel LC-MS/MS Method for Quantification of Semaglutide in Human Plasma and its Application in Pharmacokinetic Studies
Perspective
Significance of Pharmacokinetics in Maintaining Therapeutic Equivalency between Generic and Reference Pharmaceuticals
DOI: 10.35248/0975-0851.24.16.608
Regulatory and Scientific Challenges in Bioequivalence of Highly Variable Drugs
DOI: 10.35248/0975-0851.24.16.609
Therapeutic Equivalence in Pharmacogenomics and Generic Drug Development
DOI: 10.35248/0975-0851.24.16.610
Commentary
Analytical techniques for Bioequivalence Trial Drug Absorption Evaluation and Generic Medications
DOI: 10.35248/0975-0851.24.16.611
Commentary Article
Applications of Plasma Drug Concentration in Generic Drug Approval Bioequivalence Studies
DOI: 10.35248/0975-0851.24.16.612
Advancements in Pharmacodynamic Evaluation for Bioequivalence Studies
DOI: 10.35248/0975-0851.24.16.613
Opinion Article
Significance of Drug Metabolism in Bioequivalence Evaluations and Personalised Medicine
DOI: 10.35248/0975-0851.24.16.614
Pharmacogenomics and Drug-Drug Interactions in Bioequivalence Studies
DOI: 10.35248/0975-0851.24.16.615